Korro Bio (KRRO) Common Equity (2018 - 2026)
Korro Bio (KRRO) reported Common Equity of $103.23 million for Q2 2026, down 10.3% from $115.1 million a year earlier and down 13.7% from the prior quarter.
Powered by 
Analysis
Korro Bio (KRRO) Common Equity (2018 - 2026) Analysis & Trends
At the end of FY2025, Korro Bio posted Common Equity of $51.44 million, down 67.9% from FY2024.
- Common Equity has a five-year compound annual growth rate of -23.2% (FY2020 to FY2025).
- By year, Common Equity came in at $160.42 million in FY2024 (-5.6%), $169.91 million in FY2023, -$99.03 million in FY2022 and -$42.21 million in FY2021.
- Five-year quarterly Common Equity spans a low of -$153.26 million in Q3 2023 and a high of $198.08 million in Q2 2024.
- Year over year, Common Equity has now declined in each of the last seven quarters, with an average decline of 27.5% over the last seven quarters.
- Across the past five years, year-over-year decline in Common Equity ran from 5.6% in Q4 2024 to 67.9% in Q4 2025.
- Per Business Quant data, the three quarters before Q2 2026 came in at $119.63 million (Q1 2026), $51.44 million (Q4 2025) and $99.03 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 84.97 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | -5.94 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 41.98 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 41.95 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 50.37 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 11.69 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 11.83 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 85.49 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 20.25 Bn |
| 10 | Korro Bio | 145.73 Mn | -250.91 Mn | - | 103.23 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 103.23 Mn |
| Mar 31, 2026 | 119.63 Mn |
| Dec 31, 2025 | 51.44 Mn |
| Sep 30, 2025 | 99.03 Mn |
| Jun 30, 2025 | 115.10 Mn |
| Mar 31, 2025 | 138.96 Mn |
| Dec 31, 2024 | 160.42 Mn |
| Sep 30, 2024 | 179.63 Mn |
| Jun 30, 2024 | 198.08 Mn |
| Mar 31, 2024 | 151.36 Mn |
| Dec 31, 2023 | 169.91 Mn |
| Sep 30, 2023 | -153.26 Mn |
| Jun 30, 2023 | -135.40 Mn |
| Mar 31, 2023 | -118.23 Mn |
| Dec 31, 2022 | -99.03 Mn |
| Sep 30, 2022 | 81.97 Mn |
| Jun 30, 2022 | 95.85 Mn |
| Mar 31, 2022 | 112.67 Mn |
| Dec 31, 2021 | -42.21 Mn |
| Sep 30, 2021 | 147.12 Mn |
API Access
Korro Bio Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=KRRO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "KRRO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=KRRO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();